We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

The government has negotiated the world’s lowest price for a new HIV pill containing dolutegravir, but delays in awarding contracts to pharmaceutical companies have cost it almost R500m The tender was announced this week, and pushed the implementation date out from April 1 to July 1. SA has the world’s biggest HIV/AIDS epidemic and the health department’s plans to switch patients to a safer and cheaper dolutegravir-based regimen is a key part of its strategy for increasing the number of state patients from 4.2-million to 6-million by 2020-21. About 7.2-million people were living with HIV in SA in 2017, according to UNaids. SA took the first step towards introducing dolutegravir when health minister Aaron Motsoaledi and international agencies reached a breakthrough agreement with drug manufacturers in 2017 that capped the price of a generic pill combining tenofovir, lamivudine and dolutegravir (TLD) at $75 per person per year for low and middle-income countries. The Treasury has nego...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.